Bio-Rad Reports Third-Quarter 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Super Micro Computer establishes $1.25 billion stock sale agreement
Bio-Rad Labs (BIO) Misses Q3 EPS by 24c
November 1, 2018 4:39 PM EDTBio-Rad Labs (NYSE: BIO) reported Q3 EPS of $0.91, $0.24 worse than the analyst estimate of $1.15. Revenue for the quarter came in at $545.1 million versus the consensus estimate of $538.68 million.
2018 Financial Outlook
For the full year 2018, the company is reiterating the previous currency-neutral growth... More
